Cardinal Health Inc. has recalled 48 cartons of Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, after the medication was potentially exposed to temperatures outside of its required storage range. This exposure occurred due to a shipping error at a distribution center, where the refrigerated medication was removed from storage for an extended period and inappropriately released. Each recalled carton contains four single-dose prefilled pens.
Exposure to temperatures outside of the manufacturer's labeled storage conditions can compromise the safety and effectiveness of the medication, which may lead to inadequate treatment for patients using the injection.
You have 2 options:
Quantity: 48 Cartons. Manufactured by Novo Nordisk A/S.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.